IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kynam Capital Management, LP

Q1 2022 Holdings

Filed 2022-05-13 | 33 holdings | $35.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$25.6M753,03472.8%
Biogen Inc(BIIB)COM09062X103$8.1M38,23622.9%
Cabaletta BIO Inc(CABA)COM12674W109$1.3M616,1253.6%
Global Blood Therapeutics inCOM37890U108$46.4K1,339,3220.1%
Natera Inc(NTRA)COM632307104$39.3K966,4000.1%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$33.6K1,932,8000.1%
Travere Therapeutics Inc(TVTX)COM89422G107$22.4K870,9180.1%
Gossamer BIO Inc(GOSS)COM38341P102$15.9K1,832,7040.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$14.8K483,2700.0%
Vaxcyte Inc(PCVX)COM92243G108$14.0K579,6400.0%
Vera Therapeutics Inc(VERA)CL A92337R101$11.8K502,3280.0%
Viridian Therapeutics Inc(VRDN)COM92790C104$10.9K589,8260.0%
Liquidia Corporation(LQDA)COM NEW53635D202$8.3K1,159,6740.0%
Amarin Corp PLCSPONS ADR NEW023111206$7.5K2,294,0820.0%
Burning Rock Biotech LTDSPONSORED ADS12233L107$7.2K773,1140.0%
Sierra Oncology IncCOM NEW82640U404$6.2K193,2800.0%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$6.0K669,1000.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$5.4K573,5160.0%
Wave Life Sciences LTD(WVE)SHSY95308105$3.8K1,911,7280.0%
Fate Therapeutics Inc(FATE)COM31189P102$3.5K91,3370.0%
Merus N VCOMN5749R100$3.1K116,7640.0%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$2.1K291,4430.0%
Puma Biotechnology Inc(PBYI)COM74587V107$1.9K653,4450.0%
Akouos IncCOM00973J101$1.8K387,8920.0%
Radius Health IncCOM NEW750469207$1.6K185,5140.0%
Affimed N VCOMN01045108$1.5K347,9650.0%
Krystal Biotech Inc(KRYS)COM501147102$1.2K18,3930.0%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$1.2K280,8270.0%
Connect Biopharma Hldgs LTDADS207523101$688227,7590.0%
TG Therapeutics Inc(TGTX)PutCOM88322Q108$401258,6000.0%
Neoleukin Therapeutics IncCOM64049K104$264140,5080.0%
Nektar Therapeutics(NKTREUR)PutCOM640268108$260200,0000.0%
Catalyst Biosciences IncCOM NEW14888D208$70106,0890.0%